These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases. Michels MAHM; van de Kar NCAJ; Okrój M; Blom AM; van Kraaij SAW; Volokhina EB; van den Heuvel LPWJ Front Immunol; 2018; 9():612. PubMed ID: 29670616 [TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the complement pathway in C3 glomerulopathy. Zhao W; Ding Y; Lu J; Zhang T; Chen D; Zhang H; Zeng C; Liu Z; Chen H Nephrol Dial Transplant; 2018 Nov; 33(11):1919-1927. PubMed ID: 29566171 [TBL] [Abstract][Full Text] [Related]
10. Atypical hemolytic uremic syndrome and eculizumab therapy in children. Kim SH; Kim HY; Kim SY Korean J Pediatr; 2018 Feb; 61(2):37-42. PubMed ID: 29563942 [TBL] [Abstract][Full Text] [Related]
11. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H ( Cantsilieris S; Nelson BJ; Huddleston J; Baker C; Harshman L; Penewit K; Munson KM; Sorensen M; Welch AE; Dang V; Grassmann F; Richardson AJ; Guymer RH; Graves-Lindsay TA; Wilson RK; Weber BHF; Baird PN; Allikmets R; Eichler EE Proc Natl Acad Sci U S A; 2018 May; 115(19):E4433-E4442. PubMed ID: 29686068 [TBL] [Abstract][Full Text] [Related]
12. A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab. Reher D; Fuhrmann V; Kluge S; Nierhaus A Vaccine; 2018 May; 36(19):2507-2509. PubMed ID: 29631884 [TBL] [Abstract][Full Text] [Related]
13. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice. Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F Front Immunol; 2018; 9():535. PubMed ID: 29616034 [TBL] [Abstract][Full Text] [Related]
14. Complement Factor D protects mice from ethanol-induced inflammation and liver injury. McCullough RL; McMullen MR; Sheehan MM; Poulsen KL; Roychowdhury S; Chiang DJ; Pritchard MT; Caballeria J; Nagy LE Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G66-G79. PubMed ID: 29597356 [TBL] [Abstract][Full Text] [Related]
15. C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction. Bajwa R; DePalma JA; Khan T; Cheema A; Kalathil SA; Hossain MA; Haroon A; Madhurima A; Zheng M; Nayer A; Asif A Case Rep Nephrol Dial; 2018; 8(1):25-34. PubMed ID: 29594148 [TBL] [Abstract][Full Text] [Related]
16. Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria. Benz R; Krause M; Majer S; Taverna C; Herzog K Br J Haematol; 2018 Aug; 182(3):318. PubMed ID: 29676447 [No Abstract] [Full Text] [Related]
17. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K; Seeman T Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [TBL] [Abstract][Full Text] [Related]
18. Atypical hemolytic uremic syndrome: A monocentric adult Tunisian study and review of literature. Kherder-Elfekih R; Hajji M; Fatma LB; Jebali H; Mami I; Smaoui W; Krid M; Rais L; Beji S; Zouaghi K; Sellami-Kallel M Saudi J Kidney Dis Transpl; 2018; 29(2):297-302. PubMed ID: 29657196 [TBL] [Abstract][Full Text] [Related]